Walgreens Recalls Milrinone Infusions Due to Sterility Assurance Concerns
Walgreens Infusion Services is recalling Milrinone in dextrose due to lack of sterility assurance. The products were distributed in six states.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a 'Severe' severity score under the rubric, particularly given the risk of infection associated with lack of sterility assurance in infusion products.
Plain-English summary
Walgreens Infusion Services is recalling Milrinone in various strengths in dextrose. The recall is being conducted due to a lack of sterility assurance for the products.
The affected products were distributed in Texas, Florida, Virginia, Georgia, Louisiana, and Mississippi. The source text indicates that all products within their expiry dates are included in this recall.
Consumers and healthcare providers should stop using the recalled products and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Milrinone various strengths in dextrose
- Manufacturer
- Walgreens Infusion Services
- Category
- Drug — Infusion
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All products within expiry.
Distribution
Part of a larger recall action
This product is one of 36 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 36 products in this recall →Related recalls
Same manufacturer · Walgreens Infusion Services
See all →- SevereWalgreens Recalls IVIG Gamunex Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls Cefazolin Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls 0.9% Sodium Chloride/MVI Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Infusion Services Recalls Dextrose and Sodium Chloride Injection Bags
FDA (Drugs) · 2016-01-06
- HighWalgreens Recalls Famotidine Injection Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
Same hazard · infection
See all →- SevereStryker Bard EP XT Decapolar Steerable Diagnostic EP Catheter Recalled for Sterile Barrier Breach
FDA (Devices) · 2026-10-14
- SevereSafeguard US Operating LLC Recalls Compression Bandages Due to Degradation
FDA (Devices) · 2026-10-14
- HighEmbosphere Microspheres Recalled Due to Packaging Sterility Concerns
FDA (Devices) · 2026-10-07
- SevereAurolab Trust Recalls FOCUS PI Eye Drops Due to Sterility Concerns
FDA (Drugs) · 2026-10-07
- HighFDA Recalls Defective Blue Nitrile Patient Examination Gloves
FDA (Devices) · 2026-10-07
Similar recalls
- HighWalgreens Recalls Milrinone Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- HighWalgreens Recalls Insulin Syringes Due to Sterility Assurance Concerns
FDA (Drugs) · 2016-01-06
- SevereBaxter Recalls Milrinone Lactate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-05-24
- HighFDA recalls Milrinone injectable medication due to lack of sterility assurance
FDA (Drugs) · 2023-02-22
- SevereWalgreens Recalls Thiamine Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls Pedi MVI Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06